Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass
NCT02952963 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2020-11-30
Summary
The purpose of this study is to examine the efffects of bile acid and bile acids sequestrants on GLP-1 secretion, in patients after Roux-en-Y gastric bypass.
Conditions
Interventions
- DRUG
-
Chenodeoxycholic Acid
- DRUG
-
Colesevelam
Sponsors & Collaborators
-
University of Copenhagen
collaborator OTHER -
Hvidovre University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2017-12-31
- Completion
- 2020-11-30
Countries
- Denmark
Study Locations
More Related Trials
-
Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass Surgery
NCT02336659 ·Status: COMPLETED ·Phase: NA
-
Effects of Gastric Bypass Surgery on Bile Acid Homeostasis
NCT03475849 ·Status: COMPLETED
-
Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass
NCT02374632 ·Status: UNKNOWN ·Phase: PHASE4
-
Complications After Bariatric Surgery - a Clinical Trial
NCT01930838 ·Status: WITHDRAWN
-
Complications After Bariatric Surgery Based, a Questionnaire Survey
NCT01930851 ·Status: COMPLETED
-
The Effect of 'Medical Nutrition Therapy' on Post-bariatric Hypoglycemia 2-4 Years After Gastric Bypass Surgery
NCT05011682 ·Status: COMPLETED ·Phase: NA
-
Glucose Absorption and Gut Hormone Secretion After Gastric Bypass
NCT03426956 ·Status: UNKNOWN ·Phase: NA
-
Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery
NCT06278285 ·Status: RECRUITING ·Phase: NA
-
Pathogenesis of Non-alcoholic Steatohepatitis and Liver Regeneration After Bariatric Surgery
NCT02792634 ·Status: UNKNOWN
-
Prevalence of Complications After Bariatric Surgery - an Epidemiologic Survey
NCT01930929 ·Status: COMPLETED
-
The Endocrine Secretome After Gastric Bypass Surgery
NCT03093298 ·Status: COMPLETED ·Phase: NA
-
Omentectomy and Metabolic Syndrome
NCT00923260 ·Status: COMPLETED ·Phase: NA
-
Incretin Hormone Antagonism After Bariatric Surgery
NCT03950245 ·Status: COMPLETED ·Phase: NA
-
Gut Hormone Response, Appetite and Intestinal Transit Time in Good and Poor Weight Responders After Gastric Bypass
NCT00908973 ·Status: COMPLETED
-
Meal Glycaemic Index and Exercise After Gastric Bypass
NCT03478098 ·Status: COMPLETED ·Phase: NA
-
Trial of Leptin Administration After Roux-en-Y Gastric Bypass
NCT00710814 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hybrid Closed Loop Insulin Pump and Bariatric Surgery in Patients With Type 1 Diabetes
NCT06294704 ·Status: COMPLETED
-
Oral Glucosestimulation After Gastric Bypass Surgery
NCT01851616 ·Status: COMPLETED ·Phase: NA
-
Restoration of Beta Cell Function and Cardiovascular Parameters in Relation to Adipoinsular and Enteroinsular Axes After Gastric Bypass Surgery
NCT01271062 ·Status: COMPLETED ·Phase: NA
-
Fat Metabolites and Gut Hormones
NCT03223389 ·Status: UNKNOWN ·Phase: NA
-
Bariatric Surgery Versus Non-alcoholic Steato-hepatitis
NCT03524365 ·Status: COMPLETED ·Phase: NA
-
Carbohydrates and Gut Hormones After Gastric Bypass Surgery
NCT02879955 ·Status: COMPLETED ·Phase: NA
-
Surgical Innovation for Diabetes Treatment
NCT04196348 ·Status: UNKNOWN ·Phase: NA
-
Incretin Physiology and Beta-cell Function Before and After Weight-loss
NCT00625040 ·Status: TERMINATED
-
Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy
NCT00160186 ·Status: COMPLETED ·Phase: PHASE4